Agenus CEO Discusses Manufacturing Deal with Zydus, France's AAC Expansion, and Phase 3 BATMAN Trial in MSS Colorectal Cancer

Agenus has closed a manufacturing collaboration with Zydus Lifesciences, expanded France's reimbursed early access pathway, and is preparing for a global phase 3 trial in MSS metastatic colorectal cancer. The collaboration includes the sale of Agenus' biologics facility in California and an equity sale at a significant premium to market price. The deal strengthens Agenus' ability to execute its strategy by providing capital and long-term U.S.-based biologics manufacturing capacity.